Home Page: Rheumatic Disease Clinics

Time 2021-06-12 07:11:34

Web Name: Home Page: Rheumatic Disease Clinics

WebSite: http://www.rheumatic.theclinics.com

ID:182743

Keywords:

Page,Home,Rheumatic,

Description:

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your passwordEmail*If the address matches a valid account an email will be sent to __email__ with instructions for resetting your passwordCancel May 2021Pain in Rheumatic DiseasesMaripat Corr,EditorThe 5 classic signs of inflammation include redness (Latin rubor), pain (dolor), heat (calor), swelling (tumor), and loss of function. Hence, it is not surprising that pain would be a frequent concern of patients with rheumatic diseases. Treatment Update in Systemic Lupus ErythematousAlberta Y. Hoi, Eric F. MorandDOI: https://doi.org/10.1016/j.rdc.2021.04.012Publication stage: In Press Corrected ProofPreviewFull-Text HTMLPDFxThe recent updates on treatment recommendations for the management of systemic lupus erythematous have provided greater clarity in the way existing anti-inflammatory and immunomodulatory drugs are used, in treating disease activity, preventing flares, and reducing irreversible organ damage and toxicity arising from the treatments themselves. Novel therapies will provide more options in the armamentarium for treating this complex disease, but ongoing studies are needed to improve understanding of the optimal treatment algorithm to maintain quality of life and improve survival for patients.Systemic Lupus Erythematosus Classification and DiagnosisMartin Aringer, Sindhu R. JohnsonDOI: https://doi.org/10.1016/j.rdc.2021.04.011Publication stage: In Press Corrected ProofPreviewFull-Text HTMLPDFxSince the European League Against Rheumatism/American College of Rheumatology 2019 classification criteria for systemic lupus erythematosus (SLE) were published, they were externally validated by groups worldwide. In particular, the new criteria worked well also in East Asian and pediatric cohorts. Antinuclear antibodies (ANA) as an entry criterion were critically discussed, but the group of ANA-negative patients is small ( 5%) worldwide. Specificity of the criteria is dependent on correct attribution only of those criteria that are not better explained by other causes. Although the classification criteria should not be used for diagnosis, many novel aspects inform diagnostic considerations.Lupus CohortsChristopher Redmond, Omer Pamuk, Sarfaraz A. HasniDOI: https://doi.org/10.1016/j.rdc.2021.04.009Publication stage: In Press Corrected ProofPreviewFull-Text HTMLPDFxLarge cohorts with diverse ethnic backgrounds and heterogenous clinical features have provided the real-life data about the safety and efficacy of various treatment regimens for systemic lupus erythematosus (SLE). There are multiple well-established regional, national, and international lupus cohorts that have made significant contributions to the understanding of SLE. Using social media for cohort-based studies can significantly increase the outreach in a short time period for studying rare diseases such as SLE. Lack of strict inclusion criteria allows study of a broad range of patients but selection bias and incomplete data are possible in long-term cohort studies.Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical TrialsTaraneh Tofighi, Eric Morand, Zahi ToumaDOI: https://doi.org/10.1016/j.rdc.2021.04.007Publication stage: In Press Corrected ProofPreviewFull-Text HTMLPDFxThe assessment of systemic lupus erythematosus (SLE) disease activity in clinical trials has been challenging. This is related to the wide spectrum of SLE manifestations and the heterogeneity of the disease trajectory. Currently, composite outcome measures are most commonly used as a primary endpoint while organ-specific measures are often used as secondary outcomes. In this article, we review the outcome measures and endpoints used in most recent clinical trials and explore potential avenues for further development of new measures and the refinement of existing tools.Interferons in Systemic Lupus ErythematosusSirisha Sirobhushanam, Stephanie Lazar, J. Michelle KahlenbergDOI: https://doi.org/10.1016/j.rdc.2021.04.001Publication stage: In Press Corrected ProofPreviewFull-Text HTMLPDFxSkewing of type I interferon (IFN) production and responses is a hallmark of systemic lupus erythematosus (SLE). Genetic and environmental contributions to IFN production lead to aberrant innate and adaptive immune activation even before clinical development of disease. Basic and translational research in this arena continues to identify contributions of IFNs to disease pathogenesis, and several promising therapeutic options for targeting of type I IFNs and their signaling pathways are in development for treatment of SLE patients.November 2020Health Disparities in Rheumatic Diseases: Part ICandace H. Feldman, EditorAugust 2020Cancer and Rheumatic DiseasesJohn Manley Davis, EditorMay 2020Spondyloarthritis: The Changing Landscape TodayXenofon Baraliakos, Michael H. Weisman, EditorsFebruary 2020Education and Professional Development in RheumatologyKarina D. Torralba, James D. Katz, Editors2019 - Volume 45November 2019Treat to Target in Rheumatic Diseases: Rationale and ResultsDaniel Aletaha, EditorAugust 2019Controversies in RheumatologyJonathan Kay, Sergio Schwartzman, EditorsMay 2019Technology and Big Data in RheumatologyJeffrey R. Curtis, Kaleb Michaud, Kevin Winthrop, EditorsFebruary 2019Best Practices and Challenges to the Practice of RheumatologyJonathan Kay, Sergio Schwartzman, Editors2018 - Volume 44 November 2018 Renal Involvement in Rheumatic Diseases Andrew S. Bomback, Meghan E. Sise, Editors August 2018 Rheumatic Diseases in Older Adults James D. Katz, Brian Walitt, Editors May 2018 Advanced Epidemiologic Methods for the Study of Rheumatic Diseases Sindhu R. Johnson, Editor November 2016 Imaging in Rheumatic Diseases Pamela F. Weiss, Editor August 2016 Sjogren's Disease R. Hal Scofield, Editor May 2016 Patient Reported Outcomes in Rheumatic Diseases Jennifer L. Barton, MD, Patricia Katz, PhD, Editors February 2016 Corticosteroids Marcy B. Bolster, MD, Editor 2015 - Volume 41 November 2015 Psoriatic Arthritis Christopher T. Ritchlin, MD, MPH, Editor August 2015 Scleroderma Maureen D. Mayes, MD, MPH, Editor May 2015 Lung Disease in Rheumatic Diseases Aryeh Fischer, MD and Paul F. Dellaripa, MD, Editors February 2015 Vasculitis in Rheumatic Diseases Daniel A. Albert, MD, Editor 2014 - Volume 40 November 2014 Preclinical Rheumatic Disease Vivian P. Bykerk, MD, Karen H. Costenbader, MD, MPH, and Kevin Deane, MD, PhD, Editors August 2014 Systemic Lupus Erythematosus Ellen Ginzler, MD, and Mary Ann Dooley, MD, Editors May 2014 Gout and Calcium Crystal Related Arthropathies RTuhina Neogi, MD, PhD, FRCPC, Editor February 2014 Cardiovascular Rheumatic Diseases Richard Brasington, MD, Editor February 2013 Update on Osteoarthritis David J. Hunter, MBBS, MSc, PhD, FRACP, Editor November 2012 Drug Safety: Managing Innovation in Rheumatology John J. Cush, MD, and Kathryn H. Dao, MD, Guest Editors August 2012 Spondyloarthritis Jürgen Braun, MD, and Joachim Sieper, MD, Guest Editors May 2012 Early Arthritis Karina D. Torralba, MD, Richard S. Panush, MD, Francisco P. Quismorio Jr, MD, Guest Editors February 2012 Vitamin D Sol Epstein, MD, FRCP, Guest Editor November 2011 Paraneoplastic and Cancer Treatment-Related Rheumatic DisordersKenneth J. Scalapino, MD, and Charles R. Thomas Jr, MD, Guest Editors August 2011OsteoporosisStuart L. Silverman, MD, Guest Editor May 2011MyopathiesRobert L. Wortmann, MD, MACR, Guest Editor February 2011Complementary and Alternative Medicine in RheumatologySharon L. Kolasinski, MD, Guest EditorAugust 2019Controversies in RheumatologyJonathan Kay, Sergio Schwartzman, EditorsMay 2019Technology and Big Data in RheumatologyJeffrey R. Curtis, Kaleb Michaud, Kevin Winthrop, EditorsFebruary 2019Best Practices and Challenges to the Practice of RheumatologyJonathan Kay, Sergio Schwartzman, Editors2018 - Volume 44 November 2018 Renal Involvement in Rheumatic Diseases Andrew S. Bomback, Meghan E. Sise, Editors August 2018 Rheumatic Diseases in Older Adults James D. Katz, Brian Walitt, Editors May 2018 Advanced Epidemiologic Methods for the Study of Rheumatic Diseases Sindhu R. Johnson, Editor November 2016 Imaging in Rheumatic Diseases Pamela F. Weiss, Editor August 2016 Sjogren's Disease R. Hal Scofield, Editor May 2016 Patient Reported Outcomes in Rheumatic Diseases Jennifer L. Barton, MD, Patricia Katz, PhD, Editors February 2016 Corticosteroids Marcy B. Bolster, MD, Editor 2015 - Volume 41 November 2015 Psoriatic Arthritis Christopher T. Ritchlin, MD, MPH, Editor August 2015 Scleroderma Maureen D. Mayes, MD, MPH, Editor May 2015 Lung Disease in Rheumatic Diseases Aryeh Fischer, MD and Paul F. Dellaripa, MD, Editors February 2015 Vasculitis in Rheumatic Diseases Daniel A. Albert, MD, Editor 2014 - Volume 40 November 2014 Preclinical Rheumatic Disease Vivian P. Bykerk, MD, Karen H. Costenbader, MD, MPH, and Kevin Deane, MD, PhD, Editors August 2014 Systemic Lupus Erythematosus Ellen Ginzler, MD, and Mary Ann Dooley, MD, Editors May 2014 Gout and Calcium Crystal Related Arthropathies RTuhina Neogi, MD, PhD, FRCPC, Editor February 2014 Cardiovascular Rheumatic Diseases Richard Brasington, MD, Editor February 2013 Update on Osteoarthritis David J. Hunter, MBBS, MSc, PhD, FRACP, Editor November 2012 Drug Safety: Managing Innovation in Rheumatology John J. Cush, MD, and Kathryn H. Dao, MD, Guest Editors August 2012 Spondyloarthritis Jürgen Braun, MD, and Joachim Sieper, MD, Guest Editors May 2012 Early Arthritis Karina D. Torralba, MD, Richard S. Panush, MD, Francisco P. Quismorio Jr, MD, Guest Editors February 2012 Vitamin D Sol Epstein, MD, FRCP, Guest Editor November 2011 Paraneoplastic and Cancer Treatment-Related Rheumatic DisordersKenneth J. Scalapino, MD, and Charles R. Thomas Jr, MD, Guest Editors August 2011OsteoporosisStuart L. Silverman, MD, Guest Editor May 2011MyopathiesRobert L. Wortmann, MD, MACR, Guest Editor February 2011Complementary and Alternative Medicine in RheumatologySharon L. Kolasinski, MD, Guest Editor Access this journal on ScienceDirect Visit ScienceDirect to see if you have access via your institution. We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.

TAGS:Page Home Rheumatic 

<<< Thank you for your visit >>>

Hot Websites